Kazia Therapeutics (KZIA) Interest Expenses (2009 - 2011)

Kazia Therapeutics has reported Interest Expenses for 3 years, with the latest figure at -$18198.9 in Q4 2011.

• For the quarter ending Q4 2011, Interest Expenses fell 15.17% year-over-year to -$18198.9; the trailing twelve-month figure through Aug 2013 stood at -$18198.9 (changed N/A YoY), and the FY2013 full-year result was -$132389.3, changed N/A from the prior year.
• Interest Expenses for Q4 2011 stood at -$18198.9, down from -$15801.7 in the prior quarter.
• The five-year high for Interest Expenses was -$9998.5 in Q4 2009, with the low at -$18198.9 in Q4 2011.
• Historically, Interest Expenses has averaged -$14666.4 across 3 years, with a median of -$15801.7 in 2010.
• Annual changes were most pronounced in 2010 — Interest Expenses slumped 58.04% — and 2011, when it fell 15.17%.
• Kazia Therapeutics' Interest Expenses stood at -$9998.5 in 2009, then tumbled by 58.04% to -$15801.7 in 2010, then decreased by 15.17% to -$18198.9 in 2011.
• The last three Interest Expenses figures came in at -$18198.9 (Q4 2011), -$15801.7 (Q4 2010), and -$9998.5 (Q4 2009), per Business Quant data.